High-throughput, in silico prediction of aqueous solubility based on one- and two-dimensional descriptors

Journal of Chemical Information and Computer Sciences

Volumn 42, Issue 5, 2002, Pages 1247-1249

  Engkvist, Ola ^a   Wrede, Paul ^a  

^a CallistoGen AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH THROUGHPUT SCREENING (HTS);

CORRELATION METHODS; DATABASE SYSTEMS; MATHEMATICAL MODELS; MOLECULES; NEURAL NETWORKS;

SOLUBILITY;

EID: 0036757543     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci0202685     Document Type: Article

References (23)

1. Smith, D.A.; van de Waterbeemd, H.; Walker, D.K. Pharmacokinetics and Metabolism in Drug Design; Wiley-VCH, 2001.
2. Pharmacokinetic Optimisation in Drug Research; Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R., Eds.; Wiley-VCH, 2000.
3. Avdeef, A. Physicochemical Profiling (Solubility, Permeability and Charge State). Curr. Top. Med. Chem. 2001, 1, 277-351.
4. Huuskonen, J. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology. J. Chem. Inf. Comput. Sci. 2000, 40, 773-777.
5. Tetko, I.V.; Tanchuk, V.Y.; Kasheva, T.N.; Villa, A.E.P. Estimation of Aqueous Solubility of Chemical Compound Using E-State Indices. J. Chem. Inf. Comput. Sci. 2001, 41, 1488-1493.
6. Bruneau, P. Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets. J. Chem. Inf. Comput. Sci. 2001, 41, 1605-1616.
7. Liu, R.; Sun, H.; So, S.-S. Development of Quantitative Structure-Property Relationship Models for Early ADME Evaluation in Drag Discovery. 1. Aqueous Solubility. J. Chem. Inf. Comput. Sci. 2001, 41, 1633-1639.
8. Klopman, G.; Zhu, H.; Estimation of Aqueous Solubility. J. Chem. Inf. Comput. Sci. 2001, 41, 439-445.
9. Ran, Y.; Jain, N.; Yalkowsky, S.H. Prediction of Aqueous Solubility of Organic Compounds by the General Solubility Equation (GSE). J. Chem. Inf. Comput. Sci. 2001, 41, 1208-1217.
10. Peterson, D.L.; Yalkowsky, S.H. Comparison of Two Methods for Predicting Aqueous Solubility. J. Chem. Inf. Comput. Sci. 2001, 41, 1531-1534.
11. PHYSPROP (Physical/Chemical Property database), Syracuse Research Corporation, SRC Environmental Research Centre, Syracuse, New York, 1994.
12. The following rules for the elimination of undesired compounds were used: MW below 80 and above 800 are removed, the compound must contain at least one carbon. The compound must also contain at least one nitrogen, or oxygen or sulphur. The compound can have at most 6 Cl, Br and I, Only molecules consisting of the organic subset are allowed, i.e., H, C, N, P, C, S, O, F, Cl, Br and I. The following reactive groups are excluded: acylhalides, phosphanes, peroxides, isocyanates, anhydrides, acylhalides, acylcyanides, azides, cyanides and diazonium compounds. Compounds crystallized as salts are also excluded.
13. Sadowski, J.; Kubinyi, H. A Scoring Scheme for Discriminating between Drugs and Nondrugs. J. Med. Chem. 1998, 41, 3325-3329.
14. Ajay; Bemis, G.W.; Murcko, M.A. Can We Learn To Distinguish between "Drug-like" and "Nondrug-like" Molecules? J. Med. Chem. 1998, 41, 3314-3324.
15. Schneider, G.; Wrede, P. Artificial Neural Networks for Computer-based Molecular Design. Prog. BioPhys. Mol. Biol. 1998, 70, 175-222.
16. SNNS (Stuttgart Neural Network Simulator), Version 4.2; University of Tübingen, 1998.
17. Neural Networks in Chemistry and Drug Design; 2nd ed.; Zupan, J., Gasteiger, J., Eds.; Wiley-VCH: Weinheim, 1999.
18. Schneider, G.; Lee, M.L.; Stahl, M.; Schneider, P. De novo Design of Molecular Architectures by Evolutionary Assembly of Drug-derived Building Blocks. J. Comput. Aid. Drug. Des. 2000, 14, 487-494.
19. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. "Scaffold Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. Angew. Chem. 1999, 111, 3068-3070; Angew. Chem., Int. Ed. Engl. 1999, 38, 2894-2896.
20. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. "Scaffold Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. Angew. Chem. 1999, 111, 3068-3070; Angew. Chem., Int. Ed. Engl. 1999, 38, 2894-2896.
21. WDI: (Derwent World Drug Index), Version 2001/01 (Issue 18), Derwent Information Ltd., 2001. http://www.derwent.com/.
22. ACD: (Available Chemical Directory), Version 2001/01, MDL Information Systems, 2001. http://www.mdl.com/.
23. Lipinski, C.A. Drug-like Properties and the Causes of Poor Solubility and Poor Permeability. J. Pharm. Tox. Methods 2000, 44, 235-249.